Company News: Heraeus PALACADEMY® offers new online training courses for orthopaedic infection management and prevention
– New live webinar
– New Science Cast series
Heraeus PALACADEMY®, the educational platform of Heraeus Medical, features new online events on infection management in orthopaedics and traumatology with a focus on the prevention and management of periprosthetic joint infections and the relevance of local antibiotics.
Webinar as Live TV Event (submitted for CME credits)
A Live TV Event on periprosthetic joint infections (PJI) titled “How can we improve PJI prevention? Avoiding infection with antibiotic-loaded bone cement (ALBC) in high risk patients” will take place on October 6, 2020, at 20:15 / 8:15pm CET.
Speakers will be renowned experts:
- Mike Reed, M.D. (Northumbria Healthcare, University of York, UK)
- Nils Hailer, M.D. (Uppsala University Hospital, Sweden)
- Pablo Sanz-Ruiz, M.D. (Gregorio Marañon General Hospital, Spain)
- Jon Goosen, M.D. (Sint Maartenskliniek Nijmegen, the Netherlands)
- Jérôme Josse, PharmD, PhD (Institut des Sciences Pharmaceutiques et Biologiques de Lyon, University of Lyon, France)
The interactive session will include live talks, case studies, discussion, expert opinions, and live voting. The webinar is submitted for 6 CME credits.
For further information and registration, please visit the media partner channel: www.610.winglet.live
Video Podcast Series as on demand training
The new Science Cast series “Myths and truths about antibiotic-loaded bone cement (ALBC)” provides current expert knowledge and insights from international clinicians and focuses on open questions and facts on the usage and relevance of antibiotic-loaded bone cement in infection management concepts.
The series is presented by Prof. Volker Alt (University Hospital Regensburg, Germany) and supported by international guest experts such as Prof. Pablo Sanz-Ruiz (Gregorio Marañon General Hospital, Spain) and Prof. Daniel Kendoff (Helios Klinikum Berlin Buch, Germany), who will discuss evidence, basic knowledge and practice around ALBC.
The series is available as of September 24, 2020.
The first two episodes cover the topics:
- Clinical evidence for prophylactic use ALBC01.winglet.live
- Release properties and other basics ALBC02.winglet.live
About Heraeus Medical
Heraeus Medical is a leader in the area of bone cements and biomaterials for surgical orthopaedics and trauma surgery. This enables the company to make an important contribution to supporting surgeons and the surgical team and to improve surgery outcomes. In the area of biomaterials, Heraeus Medical focuses on products for use in bone and joint surgery. The core product PALACOS® is considered the gold standard among bone cements and has repeatedly proven itself for over 60 years of clinical use. The first bone cement with antibiotic for infection prophylaxis in endoprosthetics was developed more than 45 years ago with PALACOS® R+G.
A globally leading technology group, Heraeus is headquartered in Hanau, Germany. Founded in 1851, it is a family-owned portfolio company which traces its roots back to a pharmacy opened by the family in 1660. Today, Heraeus combines businesses in the environmental, energy, electronics, health, mobility and industrial applications sectors. In the 2018 financial year, Heraeus generated revenues of €20.3 billion with approximately 15.000 employees in 40 countries. Heraeus is one of the top 10 family-owned companies in Germany and holds a leading position in its global markets. With technical expertise, a commitment to excellence, a focus on innovation and entrepreneurial leadership, we are constantly striving to improve our performance. We create high-quality solutions for our clients and strengthen their long-term competitiveness by combining unique material expertise with leadership in technology.